BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6386022)

  • 1. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
    Harron DW; Deering AH; Scott M; McMahon M; Shanks RG
    Br J Clin Pharmacol; 1989 Jan; 27(1):23-9. PubMed ID: 2495813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man.
    Harron DW; Jady K; Riddell JG; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):213-20. PubMed ID: 6175803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
    De Kock MR; Detry JM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.
    Harron DW; Arndts D; Finch M; Shanks RG
    Br J Clin Pharmacol; 1983 Oct; 16(4):451-5. PubMed ID: 6626441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of temperature on the alpha-adrenoceptor antagonist potency of indoramin and labetalol in the rat perfused mesenteric vascular bed.
    McAdams RP
    J Pharm Pharmacol; 1984 Sep; 36(9):628-9. PubMed ID: 6149291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of labetalol on blood pressure in relation to the sympathetic nervous system and plasma renin activity.
    Vlachakis ND; Barr J; Velasquez M; Alexander N; Maronde R
    Clin Pharmacol Ther; 1984 Jun; 35(6):782-7. PubMed ID: 6375933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute and chronic effects of indoramin on renal function, hemodynamics, and transport.
    Morrison G; Spar B; Walker BR; Goldfarb S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S25-9. PubMed ID: 2423792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prazosin, indoramin and phentolamine on sympathetic nerve activity.
    Ramage AG
    Eur J Pharmacol; 1984 Nov; 106(3):507-13. PubMed ID: 6097460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.
    Christensen NJ; Trap-Jensen J; Svendsen TL; Rasmussen S; Nielsen PE
    Eur J Clin Pharmacol; 1978 Dec; 14(4):227-30. PubMed ID: 365539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
    Salvetti A; Pedrinelli R; Sassano P; Arzilli F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():401s-404s. PubMed ID: 396086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.